Delivery of sirna to tumor xenografted on mice using hydrogenated detonation nanodiamonds: treatment efficacy

HIGHLIGHTS

• who: Ewing sarcoma and colleagues from the Diamond Sensors Laboratory, Institut LIST, CEA, Université Paris-Saclay, Gif-sur-Yvette, France have published the research: Delivery of siRNA to Tumor Xenografted on Mice Using Hydrogenated Detonation Nanodiamonds: Treatment Efficacy, in the Journal: (JOURNAL)
• what: The authors report on the use of cationic detonation nanodiamonds (DND) for the delivery of siRNA directed against Ewing sarcoma (ES) junction oncogene EWS-FLI1 to ES tumor xenografted on mice. The authors describe an original method that the authors developed to treat ES in_vivo by injecting DND:siRNA complexes, and to . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.